Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 16 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1992 2017

Nsaid Effects on Clinical and Imaging Breast Biomarkers

Stopeck, A. T. & Thompson, P.

National Institutes of Health


Project: Research projectResearch Project

Aromatase Inhibitors
Breast Neoplasms
Diffusion Magnetic Resonance Imaging
Breast Neoplasms
Neoplasm Metastasis


Stopeck, A. T.

National Institutes of Health


Project: Research projectExploratory/Developmental Grants

Diffusion Magnetic Resonance Imaging
Drug Therapy
LDL Receptors

Research Output 1982 2017

1 Citations

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Thomson, C. A., Chow, H. H. S., Wertheim, B. C., Roe, D. J., Stopeck, A., Maskarinec, G., Altbach, M., Chalasani, P., Huang, C., Strom, M. B., Galons, J. P. & Thompson, P. A. May 30 2017 (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

Tumor Biomarkers
Randomized Controlled Trials
Breast Neoplasms
3 Citations

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Martin, M. , Holmes, F. A. , Ejlertsen, B. , Delaloge, S. , Moy, B. , Iwata, H. , von Minckwitz, G. , Chia, S. K. L. , Mansi, J. , Barrios, C. H. , Gnant, M. , Tomašević, Z. , Denduluri, N. , Šeparović, R. , Gokmen, E. , Bashford, A. , Ruiz Borrego, M. , Kim, S. B. , Jakobsen, E. H. , Ciceniene, A. & 31 others Inoue, K., Overkamp, F., Heijns, J. B., Armstrong, A. C., Link, J. S., Joy, A. A., Bryce, R., Wong, A., Moran, S., Yao, B., Xu, F., Auerbach, A., Buyse, M., Chan, A., Harvey, V., Tomek, R., Robert, N. J., Gore, I., Smith, J. W., Masuda, N., Di Sean Kendall, S., Harker, W. G., Petrakova, K., Guerrero Zotano, A., Simon, A. R., Konstantinovic, Z. N., Iannotti, N. O., Tassone, P., Rodriguez, G. I., Stopeck, A. T. & ExteNET Study Group Dec 1 2017 In : The Lancet Oncology. 18, 12, p. 1688-1700 13 p.

Research output: Contribution to journalArticle

Drug Dose Response Relationship
Neoplasm Invasiveness
Drug Administration Schedule
Antineoplastic Combined Chemotherapy Protocols
ErbB-2 Receptor

Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?

Stopeck, A. T. Jul 1 2017 In : Cancer. 123, 13, p. 2392-2394 3 p.

Research output: Contribution to journalEditorial

Breast Neoplasms

Response to letter to the Editors—Safety of long-term denosumab therapy

Stopeck, A. T. & Warner, D. J. Feb 1 2017 In : Supportive Care in Cancer. 25, 2, p. 353-355 3 p.

Research output: Contribution to journalLetter

3 Citations
Diffusion Magnetic Resonance Imaging
Linear Models
Signal-To-Noise Ratio